Point of Care Diagnostics Market is estimated to value over CAGR of over 11.2% during the forecast period 2022 to 2028. 

Growing incidences of persistent disorders along with a rise in the ageing population increases the base of consumers who are likely to get affected by various diseases steers the expansion of the global market size. As per the International Diabetes Federation (IDF), over 400 million adults worldwide were diagnosed with diabetes in 2018 and it is predicted to grow up to over 600 million cases by 2040. The POC glucose meters are substantially useful in the management of glycaemic levels that are to be observed patients suffering from diabetes.

Moreover, the factors steering the POC testing or diagnostics market growth include an increase in the number of investments made by several foundations associated with the government. As per the report published in November 2018, the National Institute of Health (NIH) provided grants of over USD 7 million to the Massachusetts Medical Device Development Center to set up a centre. This centre prioritizes on helping investors who are into point of care technologies and products.

The service decentralization of primary care in many regional markets and programs initiated by the government agencies, for instance, National Health Service, accelerate the growth of the segment. The National Science Foundation, on February 2018, awarded Houston’s Rice University with USD 10.0 million for developing a POC-based solution called mHealth device. 

Although, the home-based POC testing procedure is predicted to stand out as the fastest augmenting segment over the forecast period. The introduction of portable and economical POC-based products for early prevention and detection of diseases spur the insistence of home-based POC testing devices. Additionally, the emergence of POC in home arrangements has maintained the patient’s comfort level.

Impact of COVID-19 on Point of Care Diagnostics Market:

The University of Connecticut Health Center has developed a method based on CRISPR technology that can be used to detect diseases like COVID-19. This technology offers a highly specific, reliable and sensitive testing approach for diagnosing nuclei acid-based molecules. Furthermore, this method can be performed at room temperature, unlike the PCR-based methods, where a thermal cycler is required for maintaining temperature. But the current CRISPR detection technology requires multiple manual operations, separate amplification of nuclei acids in various reaction systems. These requirements complicate the tests, thereby risking of carrying contaminations owing to the transfer of amplified products.                   

Key players included in the global point-of-care diagnostics industry are:

Abbott, AccuBioTech, BioMérieux SA, Bio-Rad Laboratories, Becton, Dickinson, and Company, Chembio Diagnostics, Danaher, EKF Diagnostics, F. Hoffmann-La Roche, Instrumentation Laboratory, Johnson & Johnson, Nova, PTS Diagnostics, Sekisui Diagnostic, Siemens Healthineers, Sinocare Inc., Sysmex Corporation, Trinity Biotech, Trividia Health Inc., QIAGEN, Quidel.

Point of Care Diagnostics Market Segmentation:

By Product

• Glucose Monitoring Products
  o Strips
  o Meters
  o Lancets & Lancing Platform
• Cardiometabolic Testing Products
  o Cardia Marker Testing Products
  o Blood Gas/Electrolytes Testing Products
  o HBA1C Testing Products
• Infectious Disease Testing Products
  o HIV testing Products
  o Hepatitis C Testing Products
  o Sexually Transmitted Disease (STD) Testing Products
  o Healthcare-Associated Infection (HAI) Testing Products
  o Respiratory Infection Testing Products
  o Tropical Disease Testing Products
  o Other Infectious Disease testing Products
• Coagulation Testing Products
  o PT/INR Testing Products
  o Activated Clotting Time (ACT/APTT) Testing Products
• Pregnancy and Fertility Testing Products
  o Tumour/Cancer Marker Testing Products
  o Urinalysis Testing Products
  o Cholesterol Testing Products
  o Hematology testing Products
  o Drug-of-Abuse Testing Products
  o Fecal Occult Testing Products
  o Other POC Products

By Platform

  • Agglutination Assays
  • Immunoassays
  • Biosensors
  • Dipsticks
  • Lateral Flow Assays
  • Microfluidics
  • Molecular Diagnostics
  • Solid Phase

By Mode

  • Prescription-Based Testing
  • OTC Testing

By End User

  • Home Care/ Self Testing
  • Physician Offices and Outpatient Centers
  • Hospitals
  • Research Laboratories
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis 
  • Key trends 
  • Key data-points affecting market growth 

Objectives of the Study:

  • To provide with an exhaustive analysis on the global market by product, by platform, by mode, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics